Davis Jefferson E 4
4 · Acer Therapeutics Inc. · Filed Feb 5, 2021
Insider Transaction Report
Form 4
Davis Jefferson E
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-03+100,000→ 100,000 totalExercise: $3.89Exp: 2031-02-03→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 3, 2022, and the remaining 75% of the shares vest quarterly over the remaining three years.